Technology area: Biotechnology & Pharmaceuticals
1 pending office actions • 1 art units • 1 examiners • 0 of 1 (0%) have an AI response strategy ready
Hospital Sant Joan De Déu is currently navigating the patent prosecution process within the Biotechnology & Pharmaceuticals technology area. The portfolio's current activity is limited to 1 pending office action, which is being handled by 1 distinct examiner. This examiner, JAVANMARD, SAHAR, serves as the busiest examiner for the portfolio and is responsible for the 1 pending office action currently in the queue.
With 1 distinct art unit involved, the prosecution strategy is currently centralized within a specific examination group. This concentration allows for a focused approach to the pending matters, as there are no competing requirements from other examiners or art units. A practitioner should focus on the specific examination style of JAVANMARD, SAHAR, as this individual's decisions will shape the immediate future of the portfolio. The presence of 1 distinct examiner and 1 distinct art unit suggests a streamlined interaction with the USPTO for this particular technology.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §103 only | 1 (100%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| JAVANMARD, SAHAR | 1 | 64.9% | +34.1% |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18343553 | TREATMENT OF HEPATIC STEATOSIS RELATED OLIGO-OVULATION | JAVANMARD, SAHAR | — |
| Art Unit | Apps |
|---|---|
| 1622 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18343553 | TREATMENT OF HEPATIC STEATOSIS RELATED OLIGO-OVULATION | JAVANMARD, SAHAR | 1622 | §103 | Final Rejection | — | Pending | Jun 28, 2023 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free TrialHospital Sant Joan De Déu has 1 pending office actions as of October 2026, spread across 1 art units and 1 examiners.
Sahar Javanmard has the most, with 1 of Hospital Sant Joan De Déu's pending office actions.
Mostly Biotechnology & Pharmaceuticals (USPTO Tech Center 1600), based on where its pending office actions are examined.
